Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination

Learn more

Mylan has a portfolio of 7,500+ marketed products

Including biosimilars, generics, brand products and OTC remedies

Learn more

A leading voice in healthcare

CEO Heather Bresch's Blog

Read blog